P

Assignee

SERONO LAB

US55 patents

Top patents by PatentIndex Score

US5219729AJun 15, 1993

Fertility assay

SERONO LAB53 citations96
US4311688AJan 19, 1982

Composition and method for cancer detection in humans

SERONO LAB58 citations94
US7544700B2Jun 9, 2009

Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinases

SERONO LAB29 citations91
US4589402AMay 20, 1986

Method of in vitro fertilization

SERONO LAB33 citations88
US4725579AFeb 16, 1988

Method of in vitro fertilization by a unique combination of gonadotropins

SERONO LAB33 citations86
US7638480B2Dec 29, 2009

Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease

SERONO LAB10 citations82
US7417058B2Aug 26, 2008

Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases

SERONO LAB11 citations82
US4845077AJul 4, 1989

Method of inducing ovulation

SERONO LAB23 citations82
US7351526B2Apr 1, 2008

Early diagnosis of conformational diseases

SERONO LAB20 citations81
US7405197B2Jul 29, 2008

Use of hCG in controlled ovarian hyperstimulation

SERONO LAB13 citations76
US7410991B2Aug 12, 2008

Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors

SERONO LAB7 citations72
US4939124AJul 3, 1990

Treatment and diagnosis of dementia

SERONO LAB6 citations68
US4267101AMay 12, 1981

Process for obtaining human relaxin from fetal membranes

SERONO LAB17 citations67
US4001228AJan 4, 1977

2-thiol-4,5-diphenyloxazole s-derivatives

SERONO LAB8 citations64
US7635713B2Dec 22, 2009

Pyrrolidine derivatives as prostaglandin modulators

SERONO LAB3 citations62
US7589232B2Sep 15, 2009

Alkynyl aryl carboxamides

SERONO LAB4 citations62
US7335680B2Feb 26, 2008

Pyrrolidine derivatives as prostaglandin modulators

SERONO LAB2 citations62
US7291339B2Nov 6, 2007

Homogeneity and secretion of a recombinant follicle stimulating hormone (FSH) in mammalian systems

SERONO LAB1 citations62
US7312358B2Dec 25, 2007

Pharmaceutically active sulfanilide derivatives

SERONO LAB3 citations61
US7683078B2Mar 23, 2010

Arylsulfonamide derivatives as C-Jun-N-Terminal Kinases (JNK's) inhibitors

SERONO LAB2 citations59
US7393660B2Jul 1, 2008

CC-chemokine binding tick proteins

SERONO LAB2 citations59
US7365225B2Apr 29, 2008

Aryl dicarboxamides

SERONO LAB5 citations59
US7341995B2Mar 11, 2008

Use of SARP-1 for the treatment and/or prevention of scleroderma

SERONO LAB2 citations59
US7393651B2Jul 1, 2008

Confluence regulated adhesion molecules useful in modulating vascular permeability

SERONO LAB2 citations58
US7541375B2Jun 2, 2009

Azole derivatives and pharmaceutical compositions containing them

SERONO LAB3 citations57
US7326411B2Feb 5, 2008

Use of amino-terminally truncated RANTES to inhibit HIV viral replication

SERONO LAB1 citations57
US7297099B2Nov 20, 2007

Use of osteopontin for the treatment and/or prevention of neurologic diseases

SERONO LAB2 citations56
US5385841AJan 31, 1995

PO438, a new calcium-regulated promoter

SERONO LAB1 citations56
US7550563B2Jun 23, 2009

Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain

SERONO LAB2 citations55
US7297777B2Nov 20, 2007

Process of purification of hCG and recombinant hCG purified by that method

SERONO LAB2 citations54
US7335350B2Feb 26, 2008

Chemokines mutants having improved oral bioavailability

SERONO LAB1 citations51
US7638538B1Dec 29, 2009

Pharmaceutically active sulfonyl amino acid derivatives

SERONO LAB0 citations50
US7507707B2Mar 24, 2009

Methods of inducing ovulation using a non-polypeptide camp level modulator

SERONO LAB1 citations50
US7432286B1Oct 7, 2008

Pharmaceutically active sulfonyl hydrazide derivatives

SERONO LAB0 citations50
US7402303B2Jul 22, 2008

Chemokine mutants in the treatment of multiple sclerosis

SERONO LAB1 citations50
US7314878B2Jan 1, 2008

Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders

SERONO LAB1 citations49
US5089472AFeb 18, 1992

Use of growth hormone releasing factor for improving mental function

SERONO LAB2 citations49
US7470686B2Dec 30, 2008

Method of inhibiting the expression and/or the activity of JNK

SERONO LAB0 citations48
US7465441B2Dec 16, 2008

Use of gp130 activators in diabetic neuropathy

SERONO LAB1 citations47
US7338653B2Mar 4, 2008

Amino-terminally truncated MCP-2 as chemokine antagonists

SERONO LAB0 citations46
US7696231B2Apr 13, 2010

Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs)

SERONO LAB1 citations45
US7479486B2Jan 20, 2009

Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids

SERONO LAB0 citations45
US7456201B2Nov 25, 2008

Pharmaceutically active compounds and methods of use

SERONO LAB0 citations45
US7476381B2Jan 13, 2009

Methods of reducing serum alanine transferase levels in a subject with hepatitis

SERONO LAB0 citations43
US7598046B2Oct 6, 2009

Use of prion conversion modulating agents

SERONO LAB0 citations42
US7291593B2Nov 6, 2007

Use of fish for treating infertility

SERONO LAB0 citations42
US7465755B2Dec 16, 2008

Hydrazide derivatives as prostaglandin receptors modulators

SERONO LAB0 citations41
US7468385B2Dec 23, 2008

Triazoles as oxytocin antagonists

SERONO LAB0 citations40
US7557136B2Jul 7, 2009

Pyrrolidine derivatives as oxytocin antagonists

SERONO LAB0 citations38
US7465736B2Dec 16, 2008

Azole methylidene cyanide derivatives and their use as protein kinase modulators

SERONO LAB0 citations38

Showing the top 50 of 55 patents by PatentIndex Score.